UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000004662 |
|---|---|
| Receipt number | R000005554 |
| Scientific Title | Phase I clinical trial of newly developed antigen peptide vaccine for advanced esophageal cancer |
| Date of disclosure of the study information | 2010/12/03 |
| Last modified on | 2013/01/29 12:12:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Phase I clinical trial of newly developed antigen peptide vaccine for advanced esophageal cancer
Acronym
Clinical trial of peptide vaccine for esophageal cancer
Scientific Title
Phase I clinical trial of newly developed antigen peptide vaccine for advanced esophageal cancer
Scientific Title:Acronym
Clinical trial of peptide vaccine for esophageal cancer
Region
| Japan |
Condition
Condition
Advanced esophageal squamous cell carcinoma patietns treated with standart therapy includingn surgery, chemotherapy and radiotherapy, and all these treatments were failed.
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
TO confirm the safety of the newly develped pepatide vaccine for esophageal cancer
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
safety and adverse event of the peptide vaccine
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Vaccine |
Interventions/Control_1
Peptide Vaccine
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Performance status 0-2
Age 20-80 years old
WBC 2000<=, <=15000
PLT 75000<=
GOT <=150
GPT <=150
T-bil <=2.0
Cr <=2.0
HLA-A2402
Obtained written informed concent
Key exclusion criteria
Pregnancy
Lactating woman
Severe bleeding tendency
uncontroled infection
concomitant treatment with steroids
patients who are judged inappropriate for eligibility by the investigator
Target sample size
5
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Matsubara Hisahiro |
Organization
Graduate School of Medicine, Chiba University
Division name
Department of Frontier Surgery
Zip code
Address
1-8-1, Inohana, Chuoku, Chiba
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Graduate School of Medicine, Chiba University
Division name
Department of Frontier Surgery
Zip code
Address
TEL
043-222-7171
Homepage URL
Sponsor or person
Institute
Chiba University
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 12 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 01 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2012 | Year | 09 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2010 | Year | 12 | Month | 03 | Day |
Last modified on
| 2013 | Year | 01 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005554
